Syngene International Ltd — Quarterly Results & Earnings

₹389.90

-1.04%

Profit Growth YoY-36.76%Latest quarter

Sales Growth YoY2.20%Latest quarter

Sales CAGR 5Y12.60%5 year compound

Profit CAGR 5Y5.71%5 year compound

📋

Quarterly Performance

YoY Profit Growth-36.76%

🔴 Significant decline

YoY Sales Growth+2.20%

📈 Moderate growth

OPM 5Y Average

Operating profit margin

29.64%

EPS Growth 5Y

5.58%

Interest Coverage

Higher = safer debt servicing

12.45

ROE

10.53%

ROCE

13.52%

💡

Growth Analysis

Syngene International Ltd reported YoY profit growth of -36.76% and revenue growth of 2.20% in the latest quarter. Significant profit decline — requires close monitoring. Over 5 years, sales compounded at 12.60% and profits at 5.71% annually. Consistent growth over 4-8 quarters is more meaningful than any single quarter. Educational data only.

More on Syngene International Ltd

Overview Financials PE History Shareholding Quarterly Balance Sheet P&L Cash Flow Healthcare Research, Analytics & Technology Stocks Screener

Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.